Sanofi Consumer Healthcare India Limited (SANOFICONR.NS)
NSE · INR · Healthcare · Drug Manufacturers - General
₹3,383.00 (+4.10%) as of
Key statistics
- Market cap
- 78.02B
- P/E (TTM)
- 29.29
- Forward P/E
- 25.27
- EPS (TTM)
- 115.49
- Dividend yield
- 2.31%
- 52-week range
- 3,168.20 – 5,255.00
- Beta
- 0.27
- Revenue (TTM)
- 9.5B
- Profit margin
- 28.01%
- Analyst target
- ₹5,855.00
- Volume
- 15.35k
About Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. The company offers products in the allergy, physical wellness, and pain care segments under Allegra, Combiflam, Avil, DePURA, Festal, and other brand names through distributors, wholesalers, government institutions and hospitals, pharmacy chains, and e-commerce platforms. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited operates as a subsidiary of Opella Healthcare Participations B.V.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- Mumbai, India
- Employees
- 597
sanofi.com/en/india/consumer-healthcare
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.